Clinical Trial Update: CD64 Measurement in Neonatal Infection and Necrotising Enterocolitis

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating CD64 expression as a biomarker for neonatal infection and necrotizing enterocolitis (neo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis
• Neonatal Sepsis

Snippet

Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust | Conditions: Neonatal SEPSIS, Enterocolitis, Necrotizing | Status: COMPLETED